Broadwood Partners, which owns 27.5% of STAAR Surgical Company's outstanding common stock, has notified the company's Board of Directors of its intention to call a Special Meeting of shareholders. The purpose of the meeting is to remove several directors from the board, citing overwhelming shareholder opposition to the proposed acquisition of STAAR by Alcon. Broadwood has cautioned the board against delaying a shareholder vote on the transaction or making changes without substantial shareholder input. The firm calls for a refreshed board to restore shareholder trust and properly evaluate the company's strategic alternatives.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20251022937035) on October 22, 2025, and is solely responsible for the information contained therein.